KTTAW Financials

Pasithea Therapeutics Corp. - Financial statements & key metrics

Stock Price

$0.01

Market Cap

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-13.90M

EPS (Diluted)

Balance Sheet Highlights

Total Assets

$16.06M

Total Liabilities

$1.28M

Shareholders Equity

Cash & Equivalents

$6.92M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-14.56M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-0.6%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is KTTAW revenue?

View KTTAW's income statement for detailed revenue data.

Is KTTAW profitable?

KTTAW reported a loss of $13.90M in the most recent quarter.

What is KTTAW market cap?

Market cap data for KTTAW is available above.

Does KTTAW have debt?

View KTTAW's balance sheet for debt information.

What is KTTAW cash flow?

Cash flow data is available in the full financial statements.